Holen Sie sich die Stockscreener-App
6.84
0.87%
-0.06
Handel nachbörslich:
6.90
0.06
+0.88%
Schlusskurs vom Vortag:
$6.90
Offen:
$6.9188
24-Stunden-Volumen:
7,543
Relative Volume:
0.27
Marktkapitalisierung:
$4.24M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-17.06M
KGV:
-0.0967
EPS:
-70.7173
Netto-Cashflow:
$-14.18M
1W Leistung:
+2.09%
1M Leistung:
-17.12%
6M Leistung:
-48.18%
1J Leistung:
-90.84%
1-Tages-Spanne:
$6.745
$7.069
1-Wochen-Bereich:
$6.2988
$7.069
52-Wochen-Spanne:
$4.93
$114.00
Cns Pharmaceuticals Inc Stock (CNSP) Company Profile
Firmenname
Cns Pharmaceuticals Inc
Sektor
Branche
Telefon
1-800-946-9185
Adresse
2100 WEST LOOP SOUTH, HOUSTON
Vergleichen Sie CNSP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNSP
Cns Pharmaceuticals Inc
|
6.84 | 4.28M | 0 | -17.06M | -14.18M | -70.72 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.00 | 108.28B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
761.45 | 79.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.23 | 57.65B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
906.74 | 56.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
206.93 | 42.39B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cns Pharmaceuticals Inc Stock (CNSP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-12-28 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-08-24 | Eingeleitet | Ladenburg Thalmann | Buy |
Cns Pharmaceuticals Inc Aktie (CNSP) Neueste Nachrichten
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference - The Manila Times
CNS Pharmaceuticals Increases Authorized Shares for Growth - The Globe and Mail
CNS Pharmaceuticals shareholders approve share increases and board elections at annual meeting - Investing.com India
How strong is CNS Pharmaceuticals Inc. stock revenue growthWeekly Trading Summary & Weekly Stock Breakout Alerts - newser.com
How CNS Pharmaceuticals Inc. stock responds to policy changesQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - newser.com
Can CNS Pharmaceuticals Inc. stock outperform in 2025 bull marketAnalyst Downgrade & Entry and Exit Point Strategies - newser.com
Is CNS Pharmaceuticals Inc. stock gaining market shareJuly 2025 Review & AI Optimized Trade Strategies - newser.com
Is CNS Pharmaceuticals Inc. stock reversal real or fakeJuly 2025 Retail & Accurate Trade Setup Notifications - newser.com
Trend analysis for CNS Pharmaceuticals Inc. this weekJuly 2025 Momentum & Accurate Technical Buy Alerts - newser.com
Will CNS Pharmaceuticals Inc. stock deliver better than expected guidance2025 AllTime Highs & Real-Time Chart Breakout Alerts - newser.com
Full technical analysis of CNS Pharmaceuticals Inc. stockJuly 2025 Trends & Precise Trade Entry Recommendations - newser.com
Will CNS Pharmaceuticals Inc. stock gain from government policiesJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
Why CNS Pharmaceuticals Inc. stock remains resilientMarket Growth Summary & Verified Entry Point Detection - newser.com
Will CNS Pharmaceuticals Inc. stock see PE expansion2025 Geopolitical Influence & Safe Investment Capital Preservation Plans - newser.com
CNS Pharmaceuticals Reports Financial Gains Amid Ongoing R&D - TipRanks
CNS Pharmaceuticals (NASDAQ: CNSP) Reports Q3 Results and Advances Lead Candidate TPI 287 Toward Phase 2 GBM Study - Digital Journal
CNS Pharmaceuticals (CNSP) Advances Lead Product for Brain Cance - GuruFocus
CNSP Forecasts Adequate Funding to Sustain Operations into Late 2026 - GuruFocus
CNS Pharmaceuticals : Reports Third Quarter 2025 Financial Results and Provides Corporate Update - MarketScreener
CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update - ACCESS Newswire
Can volume confirm reversal in CNS Pharmaceuticals Inc.2025 Risk Factors & Low Drawdown Momentum Ideas - newser.com
Will CNS Pharmaceuticals Inc. stock return to pre crisis levelsInsider Buying & Long Hold Capital Preservation Plans - newser.com
MSN Money - MSN
Will CNS Pharmaceuticals Inc. stock recover after recent drop2025 Earnings Surprises & Technical Pattern Recognition Alerts - newser.com
Is CNS Pharmaceuticals Inc. stock dividend yield sustainableEarnings Trend Report & Weekly Return Optimization Alerts - newser.com
Finanzdaten der Cns Pharmaceuticals Inc-Aktie (CNSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.13%
4.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):